Delivery Order SPE2DB24D9802-SPE2DB25FJLCJ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,052.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Ondansetron ODT 4 mg tablets (30-count packaging) on August 12, 2025, with completion targeted for August 13, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this award,...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,568,200 units of Ondansetron ODT 8 mg tablets, a prescription medication, with a ceiling value of $1,585.22. The contract is a firm fixed-price delivery order, with a period of performance ending on May 1, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Ondansetron ODT 8 mg tablets, a prescription medication used to treat nausea and vomiting. The firm fixed-price contract has a ceiling value of $9,051.08 and a completion date of June 12, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,968.95 and a period of performance through June 11, 2024. The contract is for the delivery of Ondansetron ODT 8 mg tablets to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group has a significant...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,699.90 for Ondansetron Hydrochloride on August 11, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was issued without a set-aside designation and falls under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,555.78 contract is for the delivery of ondansetron ODT 8 mg tablets to support military medical facilities worldwide. The delivery order is part of a larger $4,999,999 indefinite delivery contract (SPE2DB) with DMS Pharmaceutical Group to provide a broad range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,758.80 contract is for the delivery of ondansetron orally disintegrating tablets, 8 mg, in 30-count packages. DMS Pharmaceutical Group holds a larger indefinite delivery/indefinite quantity (ID/IQ) contract, number 4600082013, with the Defense Logistics Agency under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,615.21 firm fixed-price delivery order is for the provision of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Ondansetron ODT 4 mg tablets and has a firm fixed price of $2,778.48 with a completion date of July 9, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLCJDelivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a ceiling value of $2,388.64. This firm fixed-price delivery order represents a continuation of the companies' established relationship under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million and extending through November 2026. The contract involves no set-aside designation, and the place of performance is Park Ridge, Illinois, where the vendor is headquartered. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has established itself as a significant supplier within the federal pharmaceutical supply chain, primarily serving Department of Defense healthcare facilities. The company specializes in distributing branded and generic prescription medications, biologics, and medical consumables to military and federal healthcare systems nationwide. Ondansetron, an antiemetic medication commonly used in medical settings, falls within the company's core portfolio of pharmaceutical products supplied through the DLA's SPE2DB program, which enables efficient procurement of diverse pharmaceutical items supporting military medical facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/18/25 |